Replies to post #655 on VIA Pharmaceuticals, Inc. (VIAP)

[mlkrborn]

On 12/29/09, VIA Pharmaceuticals, Inc. (Nasdaq:VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, announced on December 29, 2009, it received a written notice from the listing qualifications staff of the NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on January 4, 2010 and NASDAQ would initiate procedures to delist the Company's common stock.